Upvote
Downvote
Clinical Trial Manager
Share Job
- Suggest Revision
Full-time
- enGene (NASDAQ: ENGN) is a late-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, whose lead program EG-70 is being evaluated in an ongoing pivotal study for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis) who are unresponsive or naïve to treatment with Bacillus Calmette-Guérin (BCG).
- EG-70 was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. For more information, visit enGene.com.
- Contribute to the development and review of critical study documents, such as study protocol, eCRF, ICF, etc.
- Demonstrated experience with EDC, IRT and eTMF platforms
- 5+years of experience in a clinical trial experience in the pharmaceutical or biotech industry
Active Job
Updated 1 month agoSimilar Job
Relevance
Active